GSK N 261, Sakhalin Oblast

Economic indicators

Net profit (RAS) of GSK N 261 dropped in 2023 by 33.33% to 2.00 thousand RUB from 3.00 thousand RUB over the same period in 2022, the company informed.

Revenue increased in the accounting period by 22.54% to 87.00 thousand RUB from 71.00 thousand RUB over 2022.

Net profit (RAS) of GSK N 261 made up 3.00 thousand RUB over 2022 compared to net loss of 1.00 thousand RUB over 2021, the company informed.

Revenue increased in the accounting period by 7.58% to 71.00 thousand RUB from 66.00 thousand RUB over 2021.

Net loss (RAS) of GSK N 261 over 2021 was the same as in 2020 reaching 1.00 thousand RUB, the company informed.

Revenue decreased in the accounting period by 14.29% to 66.00 thousand RUB from 77.00 thousand RUB in 2020.

Revenue increased in the accounting period 1.51 times to 77.00 thousand RUB from 51.00 thousand RUB over 2019; cost of goods sold grew 1.57 times to 77.00 thousand RUB from 49.00 thousand RUB; sales profit made up 0 RUB compared to 2.00 thousand RUB.

Net profit (RAS) of GSK N 261 made up 0 RUB over 2019 compared to net loss of 1.00 thousand RUB over 2018, the company informed.

Revenue increased in the accounting period 1.65 times to 51.00 thousand RUB from 31.00 thousand RUB over 2018; cost of goods sold grew 1.53 times to 49.00 thousand RUB from 32.00 thousand RUB; sales profit made up 2.00 thousand RUB compared to sales loss of 1.00 thousand RUB.

Companies in the region

• KARVI
• KVANT-TREYD
• NERUDNYE MATERIALY
• DIL TREYD
• NAUCHNO-OBRAZOVATEL'NAYA AVTONOMNAYA NEKOMMERCHESKAYA ORGANIZATSIYA "KAZANSKIY INSTITUT MENEDZHMENTA, EKONOMIKI I SISTEM INFORMATIZATSII"